These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1384525

  • 1. Monoclonal antibodies to malignant human gliomas.
    Wikstrand CJ, Fredman P, Svennerholm L, Humphrey PA, Bigner SH, Bigner DD.
    Mol Chem Neuropathol; 1992 Oct; 17(2):137-46. PubMed ID: 1384525
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo.
    Wikstrand CJ, He XM, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD.
    J Neuropathol Exp Neurol; 1991 Nov; 50(6):756-69. PubMed ID: 1748882
    [Abstract] [Full Text] [Related]

  • 3. Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.
    Wikstrand CJ, Fredman P, Svennerholm L, Bigner DD.
    Prog Brain Res; 1994 Nov; 101():213-23. PubMed ID: 7518092
    [Abstract] [Full Text] [Related]

  • 4. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.
    Longee DC, Wikstrand CJ, Månsson JE, He X, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD.
    Acta Neuropathol; 1991 Nov; 82(1):45-54. PubMed ID: 1659106
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
    Wikstrand CJ, Longee DC, McLendon RE, Fuller GN, Friedman HS, Fredman P, Svennerholm L, Bigner DD.
    Cancer Res; 1993 Jan 01; 53(1):120-6. PubMed ID: 8416736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
    Vrionis FD, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD.
    Cancer Res; 1989 Dec 01; 49(23):6645-51. PubMed ID: 2479468
    [Abstract] [Full Text] [Related]

  • 9. Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
    Piao H, Kuan CT, Chandramohan V, Keir ST, Pegram CN, Bao X, Månsson JE, Pastan IH, Bigner DD.
    MAbs; 2013 Dec 01; 5(5):748-62. PubMed ID: 23924792
    [Abstract] [Full Text] [Related]

  • 10. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains.
    Hedberg KM, Mahesparan R, Read TA, Tysnes BB, Thorsen F, Visted T, Bjerkvig R, Fredman P.
    Neuropathol Appl Neurobiol; 2001 Dec 01; 27(6):451-64. PubMed ID: 11903928
    [Abstract] [Full Text] [Related]

  • 11. Melanoma-associated gangliosides in the fish genus Xiphophorus.
    Felding-Habermann B, Anders A, Dippold WG, Stallcup WB, Wiegandt H.
    Cancer Res; 1988 Jun 15; 48(12):3454-60. PubMed ID: 3370642
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain.
    von Holst H, Nygren C, Boström K, Collins VP, Fredman P.
    Acta Neurochir (Wien); 1997 Jun 15; 139(2):141-5. PubMed ID: 9088372
    [Abstract] [Full Text] [Related]

  • 14. Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues.
    Bernhard H, Roth S, Bauerschmitz J, Meyer zum Büschenfelde KH, Dippold W.
    Int J Cancer; 1992 Jun 19; 51(4):568-72. PubMed ID: 1376299
    [Abstract] [Full Text] [Related]

  • 15. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
    Kawashima I, Kotani M, Ozawa H, Suzuki M, Tai T.
    Int J Cancer; 1994 Jul 15; 58(2):263-8. PubMed ID: 8026889
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides.
    Fukuta S, Werkmeister JA, Burns GF, Ginsburg V, Magnani JL.
    J Biol Chem; 1987 Apr 05; 262(10):4800-3. PubMed ID: 2435716
    [Abstract] [Full Text] [Related]

  • 17. Production of monoclonal antibodies specific for ganglioside GD3.
    Watarai S, Onuma M, Yasuda T.
    J Biochem; 1991 Dec 05; 110(6):889-95. PubMed ID: 1724444
    [Abstract] [Full Text] [Related]

  • 18. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
    Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO.
    Cancer Res; 1989 Jan 01; 49(1):191-6. PubMed ID: 2908845
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunohistochemically visualized localisation of gangliosides Glac2 (GD3) and Gtri2 (GD2) in cells of human intracranial tumors.
    Mennel HD, Bosslet K, Geissel H, Bauer BL.
    Exp Toxicol Pathol; 2000 Aug 01; 52(4):277-85. PubMed ID: 10987178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.